)
)
HLS Therapeutics Investor Relations Material
Latest events
Q3 2024
HLS Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from HLS Therapeutics Inc
Access all reports
HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of prescription medications for the treatment of central nervous system (CNS) and cardiovascular conditions. The company specializes in bringing established medications to market, primarily targeting chronic conditions that require long-term treatment. HLS Therapeutics serves patients and healthcare providers across North America with a portfolio of branded medications. The company is headquartered in Toronto, Canada, and its shares are listed on the TSX.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
HLS
Country
🇨🇦 Canada